The invention relates to the anticancer medication containing oxaliplatin as the active substance, and to dendrimer oxaliplation complexes (prepared by physical methods) and oxaliplation derivative dendrimer conjugates (prepared by chemical methods) to decrease the release time and toxic effect of the said medication, and to the production methods thereof.
展开▼
